D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 70 Citations 19,157 349 World Ranking 15869 National Ranking 8278

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Surgery
  • Disease

His scientific interests lie mostly in COPD, Internal medicine, Exacerbation, Randomized controlled trial and Cardiology. He has included themes like FEV1/FVC ratio, Intensive care medicine, Lung, Severity of illness and Spirometry in his COPD study. His research investigates the link between Internal medicine and topics such as Physical therapy that cross with problems in Placebo.

His work carried out in the field of Exacerbation brings together such families of science as Eosinophil, Heart failure and Fluticasone propionate. His biological study spans a wide range of topics, including Endobronchial valve, Oncology, Mortality rate, Minimal clinically important difference and Collateral ventilation. His Vilanterol research includes elements of Clinical endpoint and Pneumonia.

His most cited work include:

  • Azithromycin for Prevention of Exacerbations of COPD (806 citations)
  • The national lung screening trial: Overview and study design (715 citations)
  • Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials (461 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of investigation include COPD, Internal medicine, Cardiology, Exacerbation and Pulmonary disease. His research in COPD intersects with topics in Vilanterol, FEV1/FVC ratio, Intensive care medicine, Physical therapy and Cohort. His research on Internal medicine frequently connects to adjacent areas such as Gastroenterology.

His Cardiology study combines topics from a wide range of disciplines, such as Airflow obstruction and Surgery. His Exacerbation study frequently draws connections to other fields, such as Randomized controlled trial. His Pulmonary disease study frequently draws connections between adjacent fields such as MEDLINE.

He most often published in these fields:

  • COPD (79.61%)
  • Internal medicine (72.23%)
  • Cardiology (24.85%)

What were the highlights of his more recent work (between 2019-2021)?

  • Internal medicine (72.23%)
  • COPD (79.61%)
  • Pulmonary disease (19.42%)

In recent papers he was focusing on the following fields of study:

Mark T. Dransfield mostly deals with Internal medicine, COPD, Pulmonary disease, Cardiology and Exacerbation. He usually deals with Internal medicine and limits it to topics linked to Gastroenterology and Chronic bronchitis. He merges COPD with In patient in his study.

His Pulmonary disease research also works with subjects such as

  • Intensive care medicine that connect with fields like Asthma and Disease,
  • Central airway, Family medicine and American Lung Association most often made with reference to MEDLINE. His studies deal with areas such as Chronotropic and Respiratory system as well as Cardiology. His Exacerbation study incorporates themes from Body mass index, Quality of life and Lung function.

Between 2019 and 2021, his most popular works were:

  • Reduction in All-Cause Mortality with Fluticasone Furoate/Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease. (26 citations)
  • Association of Dysanapsis With Chronic Obstructive Pulmonary Disease Among Older Adults. (20 citations)
  • Acute exacerbations of chronic obstructive pulmonary disease: in search of diagnostic biomarkers and treatable traits (16 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Surgery
  • Disease

His main research concerns COPD, Internal medicine, Pulmonary disease, Exacerbation and Intensive care medicine. His study in COPD focuses on Obstructive lung disease in particular. His Internal medicine study integrates concerns from other disciplines, such as Pectoralis Muscle and Cardiology.

His Pulmonary disease study combines topics in areas such as Disease progression, MEDLINE, Acute care, Healthcare utilization and Intensive care unit. His work deals with themes such as Body mass index, Precision medicine, Chronic bronchitis, Diagnostic biomarker and Lung function, which intersect with Exacerbation. His work carried out in the field of Intensive care medicine brings together such families of science as Asthma and Respiratory system.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Azithromycin for Prevention of Exacerbations of COPD

Richard K. Albert;Richard K. Albert;John Connett;William C. Bailey;Richard Casaburi.
The New England Journal of Medicine (2011)

1279 Citations

The national lung screening trial: Overview and study design

Constantine A. Gatsonis;Denise R. Aberle;Christine D. Berg;William C. Black.
Radiology (2011)

988 Citations

Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials

Steven Pascoe;Nicholas Locantore;Mark T Dransfield;Mark T Dransfield;Neil C Barnes;Neil C Barnes.
The Lancet Respiratory Medicine (2015)

707 Citations

Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD

David A. Lipson;Frank Barnhart;Noushin Brealey;Jean Brooks.
The New England Journal of Medicine (2018)

589 Citations

Pulmonary arterial enlargement and acute exacerbations of COPD.

J. Michael Wells;George R. Washko;Mei Lan K. Han;Naseer Abbas.
The New England Journal of Medicine (2012)

408 Citations

Once-daily inhaled fluticasone furoate and vilanterol versus vilanterol only for prevention of exacerbations of COPD: two replicate double-blind, parallel-group, randomised controlled trials

Mark T Dransfield;Jean Bourbeau;Paul W Jones;Nicola A Hanania.
The Lancet Respiratory Medicine (2013)

377 Citations

Simvastatin for the Prevention of Exacerbations in Moderate-to-Severe COPD

G. J. Criner;John E Connett;S. D. Aaron;R. K. Albert.
The New England Journal of Medicine (2014)

313 Citations

Prevention of Acute Exacerbations of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline

Gerard J. Criner;Jean Bourbeau;Rebecca L. Diekemper;Daniel R. Ouellette.
Chest (2015)

301 Citations

GOLD 2011 disease severity classification in COPDGene: a prospective cohort study.

MeiLan K. Han;Hana Muellerova;Douglas Curran-Everett;Mark T. Dransfield.
The Lancet Respiratory Medicine (2013)

279 Citations

Use of beta blockers and the risk of death in hospitalised patients with acute exacerbations of COPD.

Mark T Dransfield;Steven M Rowe;James E Johnson;William C Bailey.
Thorax (2008)

257 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Mark T. Dransfield

Fernando J. Martinez

Fernando J. Martinez

Cornell University

Publications: 119

MeiLan K. Han

MeiLan K. Han

University of Michigan–Ann Arbor

Publications: 107

George R. Washko

George R. Washko

Brigham and Women's Hospital

Publications: 102

Jørgen Vestbo

Jørgen Vestbo

University of Manchester

Publications: 102

Marc Miravitlles

Marc Miravitlles

Instituto de Salud Carlos III

Publications: 98

Dave Singh

Dave Singh

University of Manchester

Publications: 87

Eric A. Hoffman

Eric A. Hoffman

University of Iowa

Publications: 85

Edwin K. Silverman

Edwin K. Silverman

Brigham and Women's Hospital

Publications: 82

Bartolome R. Celli

Bartolome R. Celli

Brigham and Women's Hospital

Publications: 80

Gerard J. Criner

Gerard J. Criner

Temple University

Publications: 79

R. Graham Barr

R. Graham Barr

Columbia University

Publications: 75

Alvar Agusti

Alvar Agusti

University of Barcelona

Publications: 74

Jadwiga A. Wedzicha

Jadwiga A. Wedzicha

National Institutes of Health

Publications: 68

David A. Lynch

David A. Lynch

Children's Hospital of Philadelphia

Publications: 61

Nicolas Roche

Nicolas Roche

Université Paris Cité

Publications: 55

Peter M.A. Calverley

Peter M.A. Calverley

University of Liverpool

Publications: 54

Something went wrong. Please try again later.